ArticleCancer research2022

Neoadjuvant Intratumoral Immunotherapy with TLR9 Activation and Anti-OX40 Antibody Eradicates Metastatic Cancer.

Wan Xing Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.